OBSOLETE: Cortada-Koussef-Matsumoto syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1499
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cortada-Koussef-Matsumoto syndrome is an extremely rare genetic condition that was originally described in the medical literature based on a very small number of cases. The term is now considered obsolete in current medical classifications, meaning it may have been reclassified, merged with another condition, or its original description may no longer be recognized as a distinct syndrome. The condition was reported to involve a combination of skeletal abnormalities, facial features that differ from typical development, and other birth defects. Patients described in the original reports had features such as unusual facial appearance, limb abnormalities, and possible intellectual disability. Because this syndrome designation is obsolete, patients who were previously given this diagnosis may now fall under a different or updated diagnostic category. If you or a family member has been told about this condition, it is important to work with a clinical geneticist who can review the original findings and determine whether a more current diagnosis applies. Modern genetic testing tools, such as whole exome or whole genome sequencing, may help clarify the underlying genetic cause and guide appropriate management. Treatment has generally been supportive and symptom-based, as no specific therapy was developed for this condition.

Key symptoms:

Unusual facial featuresSkeletal abnormalitiesLimb differencesShort staturePossible intellectual disabilityBirth defects affecting multiple body systems

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Cortada-Koussef-Matsumoto syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Cortada-Koussef-Matsumoto syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Cortada-Koussef-Matsumoto syndrome community →

No specialists are currently listed for OBSOLETE: Cortada-Koussef-Matsumoto syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Cortada-Koussef-Matsumoto syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Cortada-Koussef-Matsumoto syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Cortada-Koussef-Matsumoto syndrome.

Start the conversation →

Latest news about OBSOLETE: Cortada-Koussef-Matsumoto syndrome

No recent news articles for OBSOLETE: Cortada-Koussef-Matsumoto syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Since this diagnosis is now considered obsolete, what is the most current name or classification for my condition?,Would modern genetic testing help clarify the underlying cause?,What specialists should I be seeing regularly?,Are there any specific complications I should watch for?,What therapies or support services would benefit me or my child?,Are there any related conditions I should learn about?,Can you help connect me with other families who have similar features?

Common questions about OBSOLETE: Cortada-Koussef-Matsumoto syndrome

What is OBSOLETE: Cortada-Koussef-Matsumoto syndrome?

Cortada-Koussef-Matsumoto syndrome is an extremely rare genetic condition that was originally described in the medical literature based on a very small number of cases. The term is now considered obsolete in current medical classifications, meaning it may have been reclassified, merged with another condition, or its original description may no longer be recognized as a distinct syndrome. The condition was reported to involve a combination of skeletal abnormalities, facial features that differ from typical development, and other birth defects. Patients described in the original reports had feat

At what age does OBSOLETE: Cortada-Koussef-Matsumoto syndrome typically begin?

Typical onset of OBSOLETE: Cortada-Koussef-Matsumoto syndrome is neonatal. Age of onset can vary across affected individuals.